HomeNewscoronavirusCOVID-19 crisis | Bharat Biotech setting up vaccine unit in Karnataka: Deputy CM

COVID-19 crisis | Bharat Biotech setting up vaccine unit in Karnataka: Deputy CM

The construction work has already begun and the government has invited investors to make the vaccine in State.

May 14, 2021 / 22:10 IST
File image of the Covaxin COVID-19 vaccine.

Karnataka will soon have a Covaxin-manufacturing plant of Bharat Biotech in Kolar district near here, Deputy Chief Minister of the State  said on Friday.

The construction work has already begun and the government has invited investors to make the vaccine in State, he said. "Covaxin vaccine-manufacturing plant of Bharat Biotech will be established at the earliest in Malur Industrial Area of neighbouring Kolar district," Narayan, who is the IT-BT Minister and heads the State Covid task force, said in a statement.

COVID-19 Vaccine | Covaxin dispatched to various states like Assam, Gujarat: Bharat Biotech

"The government has approved the project and the company is processing administrative requisites. Civil construction works have already been started and this will be completed soon to facilitate the functioning of the manufacturing operations as early as possible, he said. According to him, Malur, which is close to the State capital, has good transport facilities. He said the State would welcome and give full cooperation to any company engaged in the vaccine-manufacturing.

In order to combat the second wave and as a preparation to face the possible third wave, every Assembly constituency in the State needs to have a 100-bed hospital with oxygenated and ICU beds, he said.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

So far, 1.10 crore people in the State have been inoculated but vaccination for people in the age group of 18-44 has been put off due to the shortage of vaccine. The government has ordered three crore vaccines and has paid money to the manufacturers but till now so far only seven lakh vaccines have been received.

The State has reported 41,779 fresh cases and 373 fatalities despite stringent restrictions on the movement of people from April 27 till May 24.

PTI
first published: May 14, 2021 10:10 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347